ExpressionprofilesofmiR-196,miR-132,miR-146a,and miR-134inhumancolorectalcancertissuesinaccordance withtheirclinicalsignificance

ExpressionprofilesofmiR-196,miR-132,miR-146a,and miR-134inhumancolorectalcancertissuesinaccordance withtheirclinicalsignificance


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: داریوش شانه بندی , میلاد اسدی , شهریار هاشم زاده , خلیل حاجی اصغرزاده , بهزاد برادران , حسین عبدالهی

کلمات کلیدی: MicroRNA · Cancer · Quantitative realtime polymerase chain reaction · Mutation · Biomarker

نشریه: 34872 , 2021 , 9 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بهزاد برادران
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 76883
عنوان فارسی مقاله ExpressionprofilesofmiR-196,miR-132,miR-146a,and miR-134inhumancolorectalcancertissuesinaccordance withtheirclinicalsignificance
عنوان لاتین مقاله ExpressionprofilesofmiR-196,miR-132,miR-146a,and miR-134inhumancolorectalcancertissuesinaccordance withtheirclinicalsignificance
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Colorectal cancer (CRC) is among the most widespread malignancies in the world. MicroRNA (miRNA) has been identified as an important modulator of the biological processes of the cells. This group of noncoding RNAs also has a pivotal function in the growth and development of human cancers, including CRC. Among these miRNAs, miR-196, miR-132, miR-146a, and miR-134 have fundamental impacts on the regulation of cancers. The current study aimed to investigate the involvement of these miRNAs in CRC patients. Methods: In this study, 50 pairs of tumor and tumor margin samples of CRC patients were investigated to assess the expression levels of miR-196, miR-132, miR-146a, and miR-134 in this cancer. For this purpose, firstly, quantitative real-time PCR (qRT-PCR) was applied. Also, KRAS mutation and clinicopathological characteristics of the CRC patients were analyzed in the study groups. Results: The findings demonstrated the overexpression of miR-196 (P-value = 0.0045) and miR-146a (P-value = 0.0033) in tumor tissues compared to controls. Conversely, the expression levels of miR-132 (P-value = 0.00032) and miR-134 (P-value < 0.0001) were downregulated in tumor tissues. Also, miR-146a was the only miRNA with significant expression change in the case of the KRAS gene mutation. Interestingly, the expression ratio of these miRNAs was significantly associated with some of the clinicopathological features of the patients, such as lymph node and distant metastases. Conclusion: Our data demonstrated that these miRNAs appear to be promising novel biomarkers for early diagnosis of CRC and may pave the way for the future establishment of novel therapeutic options for CRC. Keywords: Biomarker; Cancer; MicroRNA; Mutation; Quantitative real-time polymerase chain reaction. © 2021. Springer-Verlag GmbH Austria, part of Springer Nature.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
داریوش شانه بندیدوم
میلاد اسدیسوم
شهریار هاشم زادهچهارم
خلیل حاجی اصغرزادهپنجم
بهزاد برادرانهفتم
حسین عبدالهیششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
550-Expression profiles of miR-196, miR-132, miR-146a, and.pdf1400/07/03882539دانلود